Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01267864 · ClinicalTrials.gov registry record · Phase 4
Valproate Versus Ketorolac Versus Metoclopramide
A Phase 4 study, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 330
- Enrollment target
NCT01267864: Completed Phase 4 study, sponsored by Montefiore Medical Center.
NCT01267864 is a Phase 4 study that has completed, run by Montefiore Medical Center. The registered enrollment target is 330 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (36% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01267864, a Phase 4 study, has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 330 participants
- Enrollment target
Study Summary
This randomized study is testing 3 different intravenous medications to see which one is best for acute migraine. The three medications are metoclopramide, valproate, and ketorolac.
Primary Outcome
Verbal Numerical Rating scale for pain. Absolute change from baseline. This is a 0-10 scale on which 0= no pain and 10= the worst pain imaginable.
Interventions
- DRUG Ketorolac
- DRUG Valproate
- DRUG Metoclopramide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 330 participants |
| Start Date | 2010-11 |
| Est. Completion | 2013-03 |
| Phase | Phase 4 |
What the finished NCT01267864 record still lists
NCT01267864 is an interventional study that assigns participants to a tested intervention. The registered 330 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (36% lower).
The record links to 0 conditions, and to 3 interventions - of which Ketorolac is the first listed.
NCT01267864 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01267864 about?
NCT01267864 is a clinical study titled "Valproate Versus Ketorolac Versus Metoclopramide". This randomized study is testing 3 different intravenous medications to see which one is best for acute migraine. The three medications are metoclopramide, valproate, and ketorolac.
What is the current status of trial NCT01267864?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 330 participants. The study started on 2010-11. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01267864?
The interventions under investigation include: Ketorolac (DRUG), Valproate (DRUG), Metoclopramide (DRUG).
Who is sponsoring clinical trial NCT01267864?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01267864's enrollment target sits among peer trials
330 253rd of 2000 higher than 1,748 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00359684 · 330 participants
Use of Cysteamine in the Treatment of Cystinosis
- NCT03817502 · 330 participants · Phase 3
Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
- NCT03922724 · 330 participants · Phase 2
Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma
- NCT03932773 · 330 participants · NA
Multi-site Confirmatory Efficacy Treatment Trial of Combat-related PTSD
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia